Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Tamsulosin/Dutasteride (Atc Code Who: G04Ca52)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 63473519

  Document Type - Tender Notices

Description - The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for medicinal products containing the active ingredient tamsulosin/dutasteride (ATC code according to WHO:G04CA52). The c ontract is concluded as part of a so-called open-house model, i. H. A contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. As a result, individual contract negotiations are not conducted and (delivery) exclusivity does not exist. It is pointed out that the purchase quantity is unknown, as this depends on demand and the development of the number o

Gt Ref Id - 63473519

Deadline - May 31, 2025